OMX30 1 574 1,1%  OMXH25 4 125 1,4%  Bitcoin 9 261,37 -0,3%  Dow 24 322 1,0%  Nas 6 650 2,1%  EUR 10,4877 0,1%  USD 8,6630 0,1%  Olja 74,6 -0,2%  Guld 1 318 0,0% 

Edwards Lifesciences Aktie

129,61USD 0,06USD 0,05%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Edwards Lifesciences Chart - 1 År - BTT

Fundamentala nyckeltal för Edwards Lifesciences

2017 2018e 2019e 2020e 2021e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 29,95 29,97 26,76 24,13 20,70
Resultat/aktie 3,80 4,53 5,08 5,63 6,56

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 129,61
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.till bolagsprofilen

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Realtidskurs Edwards Lifesciences Corp.

Bid 128,98 USD Ask 130,21 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 129,61 USD 0,06 0,05 %
Kurstid 21:59:57
Datum 26.04.2018
Öppning 129,09
Gårdagen 129,55
Dagshögsta 131,10
Dagslägsta 127,48
52 v. högsta 143,22
52 v. lägsta 100,20
52 v. perf.
Volym (Antal) 151 838
Börsvärde (SEK) 231,38 Mrd
Börsen
Kurs för 129,61 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 122,81 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 231,38 Mrd
Free float % 99,25
Antal aktier mio. 210,52
Cashflow/aktie i lokal valuta 4,63
Bokvärde/aktie i lokal valuta 14,20
60 dagar vola 28,27
PBV 8,02

Edwards Lifesciences Historiska kurser

2018-04-26 129,61 151 838
2018-04-25 129,55 336 591
2018-04-24 125,00 146 805
2018-04-23 137,22 76 609
2018-04-20 137,09 85 055